Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Korner

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
The Annals of Pharmacotherapy|October 11, 2007
Factors related to adherence to statin therapyBrandy McGinnis, Kari L Olson, David Magid, et al.
International Journal of Body Composition Research|June 29, 2010
Sex differences in visceral adipose tissue post-bariatric surgery compared to matched non-surgical controlsJ Korner, M Punyanitya, C Taveras, et al.
Der Unfallchirurg|August 24, 2004
[Monteggia injuries in adults: Critical analysis of injury pattern, management, and results]J Korner, A Hoffmann, L Rudig, et al.
Alimentary Pharmacology & Therapeutics|January 8, 2013
Absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C: results from a US database of over 45 000 HCV-infected, evaluated patientsA H Talal, J LaFleur, R Hoop, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|December 10, 2002
[Age- and gender-related distribution of bone mineral density and mechanical properties of the proximal humerus]H Lill, P Hepp, W Gowin, et al.
Journal of the American Geriatrics Society|July 5, 2007
Randomized trial to improve prescribing safety in ambulatory elderly patientsMarsha A Raebel, Jeanya Charles, Jennifer Dugan, et al.
Alimentary Pharmacology & Therapeutics|August 14, 2013
Commentary: absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C--authors' replyA H Talal, J Lafleur, R S Hoop, et al.
International Journal of Obesity (2005)|May 7, 2009
Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypassJ Korner, W Inabnet, G Febres, et al.
Alimentary Pharmacology & Therapeutics|August 29, 2013
Hepatitis C virus therapy is associated with lower health care costs not only in noncirrhotic patients but also in patients with end-stage liver diseaseS C Gordon, F M Hamzeh, P J Pockros, et al.
Pharmacotherapy|April 1, 2011
Improving prescribing safety in patients with renal insufficiency in the ambulatory setting: the Drug Renal Alert Pharmacy (DRAP) programBharati Bhardwaja, Nikki M Carroll, Marsha A Raebel, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
The Annals of Pharmacotherapy|October 11, 2007
Factors related to adherence to statin therapyBrandy McGinnis, Kari L Olson, David Magid, et al.
International Journal of Body Composition Research|June 29, 2010
Sex differences in visceral adipose tissue post-bariatric surgery compared to matched non-surgical controlsJ Korner, M Punyanitya, C Taveras, et al.
Der Unfallchirurg|August 24, 2004
[Monteggia injuries in adults: Critical analysis of injury pattern, management, and results]J Korner, A Hoffmann, L Rudig, et al.
Alimentary Pharmacology & Therapeutics|January 8, 2013
Absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C: results from a US database of over 45 000 HCV-infected, evaluated patientsA H Talal, J LaFleur, R Hoop, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|December 10, 2002
[Age- and gender-related distribution of bone mineral density and mechanical properties of the proximal humerus]H Lill, P Hepp, W Gowin, et al.
Journal of the American Geriatrics Society|July 5, 2007
Randomized trial to improve prescribing safety in ambulatory elderly patientsMarsha A Raebel, Jeanya Charles, Jennifer Dugan, et al.
Alimentary Pharmacology & Therapeutics|August 14, 2013
Commentary: absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C--authors' replyA H Talal, J Lafleur, R S Hoop, et al.
International Journal of Obesity (2005)|May 7, 2009
Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypassJ Korner, W Inabnet, G Febres, et al.
Alimentary Pharmacology & Therapeutics|August 29, 2013
Hepatitis C virus therapy is associated with lower health care costs not only in noncirrhotic patients but also in patients with end-stage liver diseaseS C Gordon, F M Hamzeh, P J Pockros, et al.
Pharmacotherapy|April 1, 2011
Improving prescribing safety in patients with renal insufficiency in the ambulatory setting: the Drug Renal Alert Pharmacy (DRAP) programBharati Bhardwaja, Nikki M Carroll, Marsha A Raebel, et al.
Pageof 5